期刊文献+

银黄充液胶囊制剂工艺研究

Study on preparation process of Yin Huang liquid capsule
下载PDF
导出
摘要 目的:筛选中药银黄充液胶囊的最佳处方并开展相关质量研究。方法:通过考察调配处方外观、分散试验、沉降试验等项目确定最佳处方组成,考察不同稀释剂、助悬剂及其用量对制剂分散效果的影响,优选最佳处方。结果:优选处方以75%聚乙二醇400为分散基质,以1.6%聚山梨酯80为助溶剂,将金银花、黄芩提取物与各辅料在50℃混匀灌装封口,混合物混悬性能好。结论:该处方工艺优选合理,质量检查及稳定性试验均符合要求,体外溶出试验表明中药银黄充液胶囊溶出效率优于普通银黄胶囊。 [Objective] To screen the best prescription of Chinese herbal medicine Yin Huang liquid caspsule. [Method]To determine the best prescription composition w ith the investigation of the distribution of the prescription,the dispersion and the settlement test. To optimize the best prescription composition by investagatingthe effect of different diluent,the suspending agent and the dosage of the suspension. [Result]Optimized prescription consisted of 75% PEG 400 as base material,1. 6% polysorbate 80 ascosolvent,and honeysuckle,scutellaria root extract mixed w ith the filling. All compositions w ere mixed uniformly and sealed at 50 C,w hich have a good suspension performance. [Conclusion]The optimized formulation process is reasonable,as quality inspection and stability w ere eligible. The result of in vitro dissolution test show ed that the dissolution efficient of medicine Yin Huang filled is superior compared w ith ordinary Yin Huang capsule.
出处 《浙江医学教育》 2015年第6期50-53,共4页 Zhejiang Medical Education
关键词 银黄胶囊 充液胶囊 高效液相色谱法 处方研究 Yin Huang capsule liquid-filled capsule HPLC prescription research
  • 相关文献

参考文献6

二级参考文献30

  • 1沈航孝,顾林金.液体灌装硬胶囊技术的研究概况[J].中国医药工业杂志,2005,36(6):377-381. 被引量:6
  • 2王春艳,张琦,于庆坤,于桂兰.正交设计筛选莪术油干混悬剂处方[J].中国医院药学杂志,2005,25(7):618-620. 被引量:1
  • 3邵凤,李桂龙,王春龙,元英进.正交设计优选银杏叶液体硬胶囊处方[J].中草药,2007,38(3):383-385. 被引量:3
  • 4RICHARDSON M, STEGEMANN S. Filling two-piece hard gelatin capsules with liquids [ J]. Tabl Caps, 2006,3 ( 1 ) : 97-110.
  • 5COLE E T, CADE D, BENAMEUR H. Challenges and oportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration [ J ]. Adv Drug Deliv Rev, 2008,60(6) :747-756.
  • 6HAUSS D J. Oral lipid-based formulations [ J ]. Adv Drug Deliv Rev, 2007,59(7) : 667-676.
  • 7STRICKLEY R G. Solubilizing excipients in oral and injectable formulations [ J ]. Pharm Res, 2004,21 ( 2 ) : 201 - 230.
  • 8sGALAL S, EL-MASSIK M, ABDALLAH O, et al. Formulation of fast release glibenclamide liquidand semi-solid matrix filled capsules [ J ]. Acta Pharm, 2003,53 ( 1 ) : 57 -64.
  • 9SCHAMP K,SCHREDER S A, DRESSMAN J. Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance [J]. Eur J Pharm Biopharm, 2006,62(3) :227-234.
  • 10BARAKAT N S. Etodolac liquid-filled dispersion into hard gelatin capsules: an approach to improve dissolution and stability of etodolac formulation [ J ]. Drug Dev Industrial Pharm, 2006,32 ( 7 ) : 865-876.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部